gea (gemcitabine, epirubicin, ABI-007)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for gea (gemcitabine, epirubicin, ABI-007), covering 2012-11-30 to 2012-11-30. Get the full timeline:
Most recent: Clinical Trial Update: Neo-adjuvant Gemcitabine, Epirubicin, ABI-007 (GEA) in Locally Advanced or Inflammatory Breast Cancer [Phase 2]